VPHM
VPHM Articles
ViroPharma Incorporated (NASDAQ: VPHM) is getting crushed on news that the Food & Drug Administration has denied the petition filed by ViroPharma on March 17, 2006 related to the FDA’s proposed...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Monday morning. Amgen Corporation (NASDAQ: AMGN) Cut to Neutral...
Published:
Last Updated:
2010 is ending and 2011 is about to begin. It has been a very interesting year for major biotech stocks, albeit with lower rewards than seen in 2009 as there have been far fewer ten-baggers with...
Published:
Last Updated:
Active traders have several big moves this morning that are on the trading radar screens. We are tracking key moves in shares of Align Technology, Inc. (NASDAQ: ALGN), Amazon.com, Inc. (NASDAQ:...
Published:
Last Updated:
Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months. The news is not even on any of the...
Published:
Last Updated:
These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Amgen Inc. (NASDAQ: AMGN) Started as Buy at Stifel Nicolaus. AngloGold...
Published:
Last Updated:
Monday is seeing many winners and losers in the healthcare sector on the heels of the health care reform passage in the House of Representatives this weekend. We are focusing solely on the biotech,...
Published:
Last Updated:
The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume analysis...
Published:
These are some of the top pre-market analyst upgrades and positive research calls we have seen from Wall Street early this Tuesday morning: Brinker International (EAT) Raised to Buy at Argus...
Published:
ViroPharma (VPHM) Drug trial fails. Huge drop to $4.89 from 52-week high of $15.16. Insight Enterprises (NSIT) Plans to restate earnings. Falls to $2.69 from 52-week high of $19.25. Popular Inc...
Published:
Last Updated:
These aren’t all of the upgrades or positive analyst calls we have seen this Wednesday, but these are some of the impact analyst calls we are seeing: BorgWarner (NYSE: BWA) Raised to Outperform...
Published: